Assignee
JN BIOSCIENCES LLC
US·8 granted patents·5 pending applications·85 citations·filing 2013–2025
Top patents by PatentIndex Score
13 records- 0197US9382319B2Hybrid constant regionsJN BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·33 cites·23 claims
- 0296US10053517B2Hybrid constant regionsJN BIOSCIENCES LLC·Filed 2016·Granted Aug 21, 2018·11 cites·21 claims
- 0396US9540442B2Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpieceJN BIOSCIENCES LLC·Filed 2013·Granted Jan 10, 2017·27 cites·21 claims
- 0492US10537633B2Antibodies to TIGITJN BIOSCIENCES LLC·Filed 2017·Granted Jan 21, 2020·13 cites·9 claims
- 0581US11332532B2Bispecific antibodies which bind PD-L1 and GITRJN BIOSCIENCES LLC·Filed 2019·Granted May 17, 2022·1 cites·17 claims
- 0677US2024317870A1Bifunctional molecules for treatment of immune disordersJN BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 0776US2024115696A1Antibodies to tigitJN BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 0874US11993657B2Bifunctional molecules for treatment of immune disordersJN BIOSCIENCES LLC·Filed 2022·Granted May 28, 2024·0 cites·25 claims
- 0971US11723971B2Antibodies to TIGITJN BIOSCIENCES LLC·Filed 2019·Granted Aug 15, 2023·0 cites·13 claims
- 1069US12492231B2Multimeric hybrid Fc proteins for replacement of IVIGJN BIOSCIENCES LLC·Filed 2019·Granted Dec 9, 2025·0 cites·11 claims
- 1169US2022251214A1Bispecific Antibodies for Activation of Immune CellsJN BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 1262US2026022174A1Trispecific Antibodies for Activation of Immune CellsJN BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 1350US2015038682A1Antibodies or fusion proteins multimerized via homomultimerizing peptideJN BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →